A comprehensive survey of cancer medicines prices, availability and affordability in Ghana.
Phyllis Ocran MattilaRichard Berko BiritwumZaheer Ud-Din BabarPublished in: PloS one (2023)
The availability of cancer medicines was very low, and less than the WHO target of 80%. There were considerable variations in the prices of different brands of cancer medicines, and affordability remains suboptimal, as most patients cannot afford the cancer medicines. Comprehensive policies, regulations and multifaceted interventions that provides tax incentives, health insurance, and use of generics to improve cancer medicines availability, prices, and affordability, for the masses should be developed and implemented in Ghana.